Yong Ben - 30 May 2025 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Director
Signature
/s/ Meghan Houghton, attorney-in-fact for Yong Ben
Issuer symbol
CRBP
Transactions as of
30 May 2025
Transactions value $
$0
Form type
4
Filing time
02 Jun 2025, 16:30:15 UTC
Previous filing
03 Jun 2024
Next filing
18 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ben Yong Director C/O CORBUS PHARMACEUTICALS HOLDINGS, INC, 500 RIVER RIDGE DRIVE, NORWOOD /s/ Meghan Houghton, attorney-in-fact for Yong Ben 02 Jun 2025 0001967669

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRBP Common Stock, par value $0.0001 per share Award $0 +4.8K +172.48% $0.00 7.58K 30 May 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Stock options (right to buy) Award $0 +16K $0.00 16K 30 May 2025 Common Stock 16K $7.42 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 30, 2025, 4,800 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant.
F2 This amount includes 4,800 unvested RSUs that were granted on May 30, 2025.
F3 The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant.